What's breaking now, across thousands of outlets.
MUNICH — CRISPR Therapeutics’ gene editing candidate showed mixed durability results a year after patients were dosed, according to early-stage data presented Friday at the annual meeting of the European Society of Cardiology. The company will ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The Federal Government stresses that cancer patient care must continue even when a cure isn’t possible. Hospitals urged not to send patients home premature Read More…
The Federal Government stresses that cancer patient care must continue even when a cure isn’t possible. Hospitals urged not to send patients home premature Read More…
Tributes pour in for country music icon and humanitarian Dolly Parton. Thousands of fans signed a petition asking officials to name Nashville's airport after her.
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
The Komfo Anokye Teaching Hospital (KATH) has recorded a significant drop in maternal deaths, a development the hospital’s management says marks its first major turning point in a decade in efforts to…
A new MRI-based tool could offer clues about what lies ahead, giving families a clearer look at disease progression.
